After years of raking in billions of dollars from its Tenofovir Disoproxil Fumarate (TDF) drug monopoly, Gilead Sciences will have to face competition from the first wave of generic TDF drugs which were recently launched by Israeli drug manufacturer Teva Pharmaceuticals. On October 2, 2020, Teva announced the launch and pricing of long-awaited generic versions …
Last week, the Missouri Supreme Court shot down Johnson & Johnson’s bid to appeal a $2.1 billion jury verdict in favor of women who blamed their ovarian cancer on the company’s baby powder. In 2018, a St. Louis jury found that J&J’s talc-based powder products were the leading cause of ovarian cancer for 20 women …
J&J Loses Bid to Appeal $2.1 Billion Talc Powder Verdict Read More »
The FDA continues to recommend manufacturer recalls of the popular diabetes medication metformin after testing shows the presence of a known carcinogen, N-nitrosodimethylamine, more commonly known as NDMA. On October 5, 2020, the FDA alerted patients and health care professionals of two new metformin recalls for products manufactured by Marksans Pharma and Sun Pharmaceutical for …
FDA Recalls Metformin After Finding Known Carcinogen Read More »
